Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Robyn Fink"'
Autor:
Patrice K. Rehm, William W. Grosh, Galina V. Yamshchikov, Cheryl F. Murphy, Mark E. Smolkin, Kimberly A. Chianese-Bullock, Craig L. Slingluff, Patrice Y. Neese, Gina R. Petroni, Robyn Fink, Sarah Hibbitts, James W. Patterson, Naomi Johansen
Publikováno v:
Clinical Cancer Research. 13:6386-6395
Purpose: Human melanoma cells express shared antigens recognized by CD8+ T lymphocytes, the most common of which are melanocytic differentiation proteins and cancer-testis antigens. However, peptide vaccines for melanoma usually target only one or tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b2840866fa9c785aad7a69af2e07dad
https://doi.org/10.1158/1078-0432.ccr-07-0486
https://doi.org/10.1158/1078-0432.ccr-07-0486
Autor:
Carmel J. Nail, Patrice Y. Neese, Patrice K. Rehm, Andrea Czarkowski, Kimberly A. Chianese-Bullock, Donna H. Deacon, Gina R. Petroni, Mark E. Smolkin, Craig L. Slingluff, Robyn Fink, Walter C. Olson, William W. Grosh, Priscilla Merrill, James W. Patterson
PurposeA phase I/II trial was performed to evaluate the safety and immunogenicity of a novel melanoma vaccine comprising six melanoma-associated peptides defined as antigenic targets for melanoma-reactive helper T cells. Source proteins for these pep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f1ff2a6b6765e211770c5957ec2b19
https://europepmc.org/articles/PMC2652084/
https://europepmc.org/articles/PMC2652084/
Autor:
Galina V. Yamshchikov, Priscilla Merrill, Sarah Hibbitts, William W. Grosh, Cheryl F. Murphy, Robyn Fink, Kimberly A. Chianese-Bullock, Jennifer Pressley, Craig L. Slingluff, Catherine J. Wiernasz, Elizabeth M. H. Woodson, Gina R. Petroni, Eric A. Bissonette, Patrice Y. Neese, Courtney F. Garbee, James W. Patterson
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 174(5)
Twelve peptides derived from melanocyte differentiation proteins and cancer-testis Ags were combined and administered in a single mixture to patients with resected stage IIB, III, or IV melanoma. Five of the 12 peptides included in this mixture had n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6201b6a18e65ca2ef6257ac3a6de77b
https://pubmed.ncbi.nlm.nih.gov/15728523
https://pubmed.ncbi.nlm.nih.gov/15728523
Autor:
Craig L. Slingluff, William W. Grosh, Robyn Fink, Sarah Hibbitts, Gina R. Petroni, Cheryl F. Murphy, K. A. Bullock, N. Anderson, Patrice Y. Neese, E. Bissonnette
Publikováno v:
Journal of Clinical Oncology. 22:7503-7503
7503 Background: To evaluate the immunogenicity of 12 peptides from cancer-testis and melanocyte differentiation proteins, and to assess the feasibility of complex peptide vaccines, a randomized phase II trial was performed in 51 patients with resect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8280309579c13c3940e214686b6816f5
https://doi.org/10.1200/jco.2004.22.90140.7503
https://doi.org/10.1200/jco.2004.22.90140.7503
Autor:
Kimberly A. Chianese-Bullock, Erin M Farris, Jonathan H Fink, Andrea Czarkowski, Mark E. Smolkin, Robyn Fink, Craig L. Slingluff, Walter C. Olson
Publikováno v:
Journal of Translational Medicine, Vol 9, Iss 1, p 26 (2011)
Journal of Translational Medicine
Journal of Translational Medicine
Background Clinical trials of immunologic therapies provide opportunities to study the cellular and molecular effects of those therapies and may permit identification of biomarkers of response. When the trials are performed at multiple centers, trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78cd538e0847e73c257e6acb1cf9d9f6